VEGFA and laryngotracheoesophageal cleft: Vascular endothelial growth factor (VEGF)-A (encoded by VEGFA) enhances the metastasis and angiogenesis of LC cells and thereby contribute to the progression of LC, and its activation profile is related to a poor clinical prognosis and the survival of patients with LC [81–86].